TheraSphere for the Treatment of Liver Metastases

Clinical trial NCT00511862 · COMPLETED

Trial details

NCT number: NCT00511862
Sponsor: Boston Scientific Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Carcinoma, Neuroendocrine Neoplasm Metastasis

Start date: 2007-01-01
Primary completion: 2011-03-01
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.